Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$61.9M |
| 2 |
Coca-Cola
KO
|
+$46.9M |
| 3 |
Broadcom
AVGO
|
+$46.8M |
| 4 |
SLB Ltd
SLB
|
+$40.3M |
| 5 |
Netflix
NFLX
|
+$40.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$76.6M |
| 2 |
Johnson & Johnson
JNJ
|
+$75.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$49.3M |
| 4 |
Tradeweb Markets
TW
|
+$48M |
| 5 |
Visa
V
|
+$40.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 26.52% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Discretionary | 12.77% |
| 4 | Technology | 5.33% |
| 5 | Financials | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Illumina
ILMN
$28.4B
| $749K | ﹤0.01% |
5,608
+1,240
| +28% | +$204K |
|
652
Bausch Health
BHC
$2.34B
| $746K | ﹤0.01% |
90,162
+2,474
| +3% | +$21.3K |
|
653
Advanced Drainage Systems
WMS
$10.9B
| $744K | ﹤0.01% |
+6,533
| New | +$798K |
|
654
Autoliv
ALV
$9B
| $742K | ﹤0.01% |
7,695
-531
| -6% | -$50.9K |
|
655
iRhythm Holdings
IRTC
$4.2B
| $719K | ﹤0.01% |
7,627
-25,574
| -77% | -$2.6M |
|
656
Itron
ITRI
$4.54B
| $701K | ﹤0.01% |
11,566
+825
| +8% | +$56.6K |
|
657
Meritage Homes
MTH
$4.86B
| $698K | ﹤0.01% |
+11,398
| New | +$783K |
|
658
W.P. Carey
WPC
$16.4B
| $687K | ﹤0.01% |
12,971
-14,301
| -52% | -$916K |
|
659
Royal Gold
RGLD
$19.5B
| $685K | ﹤0.01% |
+6,444
| New | +$732K |
|
|
SILK
660
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $678K | ﹤0.01% |
45,227
+3,644
| +9% | +$75.8K |
|
|
ATRI
661
DELISTED
Atrion Corp
ATRI
| $676K | ﹤0.01% |
1,636
+145
| +10% | +$72.8K |
|
662
Alamos Gold
AGI
$13.9B
| $676K | ﹤0.01% |
59,862
-43,825
| -42% | -$527K |
|
663
Integer Holdings
ITGR
$4.26B
| $662K | ﹤0.01% |
8,447
-27,507
| -77% | -$2.33M |
|
664
Sunrun
RUN
$2.46B
| $659K | ﹤0.01% |
52,440
-3,656
| -7% | -$60.1K |
|
665
Fulgent Genetics
FLGT
$527M
| $657K | ﹤0.01% |
24,563
+2,402
| +11% | +$82K |
|
666
Treace Medical Concepts
TMCI
$309M
| $655K | ﹤0.01% |
+49,962
| New | +$914K |
|
667
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $651K | ﹤0.01% |
8,826
-2,127
| -19% | -$159K |
|
668
Domino's
DPZ
$11.6B
| $639K | ﹤0.01% |
1,686
+153
| +10% | +$58.9K |
|
669
Outset Medical
OM
$90.8M
| $637K | ﹤0.01% |
3,905
+409
| +12% | +$96.5K |
|
|
AGR
670
DELISTED
Avangrid, Inc.
AGR
| $612K | ﹤0.01% |
20,284
+2,204
| +12% | +$77.9K |
|
671
Edison International
EIX
$26.4B
| $602K | ﹤0.01% |
9,504
+967
| +11% | +$67.4K |
|
672
Watsco Inc
WSO
$13.6B
| $595K | ﹤0.01% |
+1,575
| New | +$569K |
|
673
OrthoPediatrics
KIDS
$595M
| $594K | ﹤0.01% |
18,567
+6,288
| +51% | +$242K |
|
674
Charles River Laboratories
CRL
$12.8B
| $589K | ﹤0.01% |
3,005
-1,301
| -30% | -$267K |
|
675
HubSpot
HUBS
$10.5B
| $584K | ﹤0.01% |
1,186
+109
| +10% | +$56.9K |
|
Similar funds
Ray Dalio's Q3 2023 Portfolio in Review
As of Q3 2023, Ray Dalio held 826 positions worth $16.5B, up 2.2% from $16.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ray Dalio deployed $1.1B of net new capital in Q3 2023, opening 130 new positions and adding to 388 existing holdings. Its largest new stake was Broadcom: 540,410 shares worth $44.9M.
By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $76.6M trimmed.
- Ray Dalio's largest Q3 2023 buy was Broadcom: 540,410 shares worth $44.9M.
- Ray Dalio added most to iShares Core MSCI Emerging Markets ETF in Q3 2023, an estimated $61.9M increase.
- Ray Dalio's biggest Q3 2023 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $76.6M.
- Ray Dalio fully exited Corteva in Q3 2023, selling an estimated $19M.
- Ray Dalio's ten largest holdings make up 34% of its $16.5B portfolio in Q3 2023.
- Ray Dalio opened 130 new positions and closed 86 in Q3 2023.
- Ray Dalio's portfolio value rose 2.2% quarter-over-quarter to $16.5B.
Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.